Medicine and Dentistry
Therapeutic Procedure
100%
Melanoma
93%
Patient
67%
Antibody-Drug Conjugate
39%
Triple Negative Breast Cancer
37%
Neoplasm
33%
Immunity
26%
Mechanism of Action
24%
Immune Checkpoint Inhibitor
24%
Protein
18%
Folate Receptor 1
18%
Proteochondroitin Sulfate
18%
B Cell
18%
Cytotoxic T-Cell
18%
Antifolate
18%
Antibody Therapy
18%
Cancer Model
18%
DNA
18%
Cyclin-Dependent Kinase
18%
Cancer Cell
17%
Monotherapy
17%
Therapeutics
16%
Immune Response
12%
Breast Cancer
12%
Clinical Management
10%
T Cell
9%
In Vitro
9%
Immune-Related Adverse Events
8%
Tumor Regression
6%
Gene
6%
Immunoglobulin G1
6%
Hematological Cancer
6%
Vascularity
6%
Programmed Death 1 Receptor
6%
Cancer
6%
Non-Hodgkin Lymphoma
6%
Experience
6%
Tumor Xenograft
6%
Xenograft
5%
Toxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
57%
Folic Acid Antagonist
18%
Antibody Structure
18%
Mitogen Activated Protein Kinase
9%
Saporin
7%
Antitumor Activity
7%
Immunology and Microbiology
Programmed Death-Ligand 1
27%
B Cell
18%
Antibody Structure
18%
Antibody Engineering
18%
Xenograft
18%
Isotype
5%
